Jaguar Health, Inc.

Halal Rating :
To Be Determined
See Details
Last Price $0.11 Last updated:
Market Cap $17.71m
7D Change -6.56%
1 Year Change -84.44%

Company Overview

  • Health Technology
  • Pharmaceuticals: Generic
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing
Exchange NASDAQ
Next Earnings Date Nov. 14, 2023

Jaguar Health, Inc., a commercial-stage pharmaceutical company, focuses on developing prescription drugs for people and animals with gastrointestinal upset, specifically chronic debilitating diarrhea. The company is headquartered in San Francisco, California.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2023 $3.2m $12.59m - $500000.0 0.00% 3.97%
June 30, 2023 $2.68m $14.72m - $3.45m 0.00% 23.46%

Company Impact

Help us evaluate Jaguar Health, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates